Latest news - Zinereo Pharma

All Events1 News8 Press8 Probiotics4 Subsidies1 Uncategorized1 Zendal Group2 Zinereo Pharma8

20/10/2024

··

Agreement with Cigalah Medpharm in the Middle East

We announced a strategic partnership to expand our innovative probiotics portfolio in the Middle East with an exclusive agreement with Cigalah Medpharm. The Fertibiome and Flowbiotic brands will reach 6…

21/09/2024

··

News, Press, Zinereo Pharma

Agreement with RiteMED Phils in the Asian Market

September 2024 We announce our exclusive distribution agreement with RiteMED Phils for the launch of Fertibiome, a breakthrough in reproductive health, in the Philippines. This partnership with Fervida, a division…

09/08/2024

··

News, Press

Launch of Reutopic at Colombia’s Veterinary Congress

Pereira, August 7-9, 2024 In partnership with Euroetika, our exclusive distributor, we successfully introduced Reutopic, an innovative solution for canine atopic dermatitis, at Colombia’s premier veterinary congress. The launch featured…

02/07/2024

··

Subsidies, Uncategorized, Zinereo Pharma

Zinereo Pharma receives funding from IGAPE’s “GRANTS FOR LARGE COMPANIES IN FOEXGA 2024 – CALL FOR COMMERCIAL MISSION TO THE USA

Last week, our Global Business Development Director, Ana Nunes, went on a Business Trip to the USA. In Salt Lake, she attended Probiota Americas and an IPA Board meeting. In…

04/06/2024

··

News, Press, Probiotics

Launch of Giniwa, Flowbiotic, and Fertibiome in Mozambique

Maputo, 28th May – 4th June, 2024 We successfully launched our probiotic brands Giniwa, Fertibiome, and Flowbiotic in Mozambique, focused on women’s and intestinal health, through an exclusive partnership with…

20/05/2024

··

News, Press

Interview Porto Canal

In may Ana Nunes, our Global Business Development Director, was interviewed by Porto Canal, a Portuguese television channel, to dive into the fascinating links between Digestive Health and the Microbiome.…

27/02/2024

··

News, Press

Ana Nunes as a member of the IPA Board of Directors

We are delighted to announce that Ana Nunes, our Global Business Development Director, has been elected as a member of the Board of Directors of the International Probiotics Association (IPA).…

15/05/2019

··

Events, Zinereo Pharma

Zinereo Pharma Probióticos present in Vitafoods Europe

Zinereo Pharma and its subsidiaries, Bialactis y Probisearch, attended Vitafoods Europe, the International Nutraceutics event held in Geneva (Switzerland) from 7 to 9 May 2019. The event, considered to be…

15/03/2019

··

News, Probiotics, Zinereo Pharma

Zinereo Pharma launches its 1st line of probiotics for sports nutrition: TOP4U

Today we have launched our TOP4U products, the first line of probiotics specifically for sports nutrition. It is a product line consisting por 8 different products with different characteristics to meet…

29/11/2018

··

News, Press

Zendal launches its line of probiotics with a capital injection in its subsidiary Bialactis Biotech

The Zendal group has decided to strengthen its business line of pharmaceutical-quality probiotics with a capital injection for the “ambitious international expansion plan” of its Porriño-based subsidiary Bialactis. According to…

29/11/2018

··

Zendal Group, Zinereo Pharma

The Zendal brand is created to integrate all the companies of the Spanish biotechnology group made up of CZ Veterinaria and Biofabri

The biotechnology companies specialized in human and animal healthcare and prevention CZ Veterinaria, Biofabri, Bialactis, Probisearch, Vetia and Petia have a new umbrella brand. CZ Veterinaria, their parent company and…

29/11/2018

··

Probiotics, Zendal Group, Zinereo Pharma

The biotechnology company Zendal launches a subsidiary exclusively for probiotics

The Galician biotechnology group Zendal, known as CZ-Biofabri until the end of last year, has just announced the launch of a new subsidiary called Zinereo Pharma, which will focus entirely…

News

Aviso de cookies